Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruconest for Acute HAE Attacks
NCT01188564Phase 3Completed
- Sponsor
- Pharming Group
- Start
- Jan 2011
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 11
01
Overview
A Phase 3 trial of c1-esterase inhibitor in hereditary angioedema (HAE), sponsored by Pharming Group. Started Jan 2011; status: completed.
02
Drugs
c1-esterase inhibitor
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on NCT01188564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01188564.